CRLF2 and acute lymphoblastic leukemia: We next tested MUTZ5 and MHH-CALL-4 as two BCP-ALL cell lines that should be sensitive to this drug: both cell lines overexpress CRLF2 via an IGH@-CRLF2 translocation.